Generative AI Powers Mental Healthcare: Wangli Technology Secures Multi-Million Dollar Funding Round

product #llm 📝 Blog|Analyzed: Mar 2, 2026 00:00•

Published: Mar 2, 2026 00:00

•

1 min read

Analysis

Wangli Technology is revolutionizing mental healthcare by integrating Generative AI into its digital mental health platform. This infusion of funds will accelerate product development, especially the development of their innovative iCBT (internet-based cognitive behavioral therapy) product for depression, which has already received regulatory approval.

Key Takeaways

•Wangli Technology leverages a Multimodal Large Language Model and specialized Reinforcement Learning algorithms.
•The company has developed a unique "three-level recommendation engine" for personalized interventions.
•Their iCBT product, "Wangli Sunny," is now recommended by the Chinese Depression Prevention and Treatment Guidelines.

Reference / Citation

View Original

"In 2025, Wangli Technology's anti-depressant product based on digital psychological treatment (iCBT) received the third-class medical device registration certificate, becoming the first digital medical product in the field of anti-depressant and mental/neurological disease treatment in China."

36氪Mar 2, 2026 00:00

* Cited for critical analysis under Article 32.

Older

Supercharge Your Claude Code: A Guide to Optimizing AI-Generated Code

Newer

Global Impact: AI in Military Operations & Business Restructuring